Q3 2019 Chugai Pharmaceutical Co Ltd Earnings Call Transcript
Good evening, ladies and gentlemen. I am Toshiaki Itagaki of Chugai Pharmaceutical Co., Ltd. Thank you very much for joining us for this conference call at this late hour. I hope you will stay with us until the end.
Please take a look at Page 2, which is a 1-page summary of the financial results. We have achieved a double-digit growth, both in revenues and profits, significantly exceeding the previous year's results, posting record highs as Q3 performances in revenues, operating profit and net income.
Revenues reached JPY 508.9 billion, topping the JPY 500 billion mark in 9 months for the first time ever. Operating profit recorded JPY 171.1 billion, which was the highest ever, even compared to any past full year's results with operating margin at 33.6%. The net income was JPY 124.5 billion, exceeding JPY 100 billion for the first time, even for a full year's figure.
Both operating profit and EPS have already overachieved our original full year
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
